Personal information

Japan

Activities

Employment (4)

The Jikei University School of Medicine: Tokyo, JP

2017-04-01 to present | Assistant Professor (Department of Urology)
Employment
Source: Self-asserted source
Wataru Fukuokaya

Tokyo Medical and Dental University: Tokyo, JP

2024-04-01 to 2028-03-31 | PhD student (Department of Clinical Biostatistics)
Employment
Source: Self-asserted source
Wataru Fukuokaya

JCHO Tokyo Shinjuku Medical Center: Tokyo, JP

2015-04-01 to 2017-03-31 | Junior Resident
Employment
Source: Self-asserted source
Wataru Fukuokaya

University of Miyazaki: Miyazaki, JP

2013-03-01 to 2015-03-31 | Research Assistant (Neurology,Respirology,Endocrinology and Metabolism, Department of Internal Medicine)
Employment
Source: Self-asserted source
Wataru Fukuokaya

Education and qualifications (2)

Tokyo Medical and Dental University: Tokyo, JP

2024-04-01 to 2028-03-31 (Department of Clinical Biostatistics)
Education
Source: Self-asserted source
Wataru Fukuokaya

University of Miyazaki: Miyazaki, JP

2009-04-01 to 2015-03-31 | M.D. (Faculty of Medicine)
Education
Source: Self-asserted source
Wataru Fukuokaya

Professional activities (3)

European Association of Urology: Arnhem, NL

2018-04-01 to present
Membership
Source: Self-asserted source
Wataru Fukuokaya

American Society of Clinical Oncology: Alexandria, VA, US

2018-04-01 to present
Membership
Source: Self-asserted source
Wataru Fukuokaya

The Japanese Urological Association: Tokyo, JP

2017-04-01 to present
Membership
Source: Self-asserted source
Wataru Fukuokaya

Funding (3)

新規ARシグナル経路制御因子JMJD1Cの前立腺癌における機能解析と臨床応用

2020-04-01 to 2024-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 20K18102
Source: Self-asserted source
Wataru Fukuokaya via DimensionsWizard

Elucidation of systemic regulatory mechanisms of cognitive function

2015-04-01 to 2017-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 15K12703
Source: Self-asserted source
Wataru Fukuokaya via DimensionsWizard

Identification and analyses on inductive pathway in impairment of memory and learning caused by chronic intake of high fat diet

2014-04-01 to 2017-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 26282026
Source: Self-asserted source
Wataru Fukuokaya via DimensionsWizard

Works (50 of 73)

Items per page:
Page 1 of 2

Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis

International Journal of Urology
2024 | Journal article
EID:

2-s2.0-85174149406

Part of ISSN: 14422042 09198172
Contributors: Mori, K.; Yanagisawa, T.; Fukuokaya, W.; Iwatani, K.; Matsukawa, A.; Katayama, S.; Pradere, B.; Laukhtina, E.; Rajwa, P.; Moschini, M. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab

International Journal of Clinical Oncology
2024 | Journal article
EID:

2-s2.0-85186948246

Part of ISSN: 14377772 13419625
Contributors: Hashimoto, M.; Fukuokaya, W.; Yanagisawa, T.; Yamamoto, S.; Koike, Y.; Imai, Y.; Iwatani, K.; Onuma, H.; Ito, K.; Urabe, F. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma

Anticancer Research
2024 | Journal article
EID:

2-s2.0-85191637630

Part of ISSN: 17917530 02507005
Contributors: Fukuokaya, W.; Akazawa, K.; Kimura, T.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Bone-Modifying Agents in Patients with High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated with Abiraterone Acetate

JAMA Network Open
2024 | Journal article
EID:

2-s2.0-85187965217

Part of ISSN: 25743805
Contributors: Fukuokaya, W.; Mori, K.; Urabe, F.; Igarashi, T.; Yanagisawa, T.; Tsuzuki, S.; Honda, M.; Miki, K.; Kimura, T.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan

Journal of Cancer Research and Clinical Oncology
2024 | Journal article
EID:

2-s2.0-85190334746

Part of ISSN: 14321335 01715216
Contributors: Hirasawa, Y.; Adachi, T.; Hashimoto, T.; Fukuokaya, W.; Koike, Y.; Yata, Y.; Komura, K.; Uchimoto, T.; Tsujino, T.; Nishimura, K. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Comparison of the Efficacy of Enfortumab Vedotin between patients with Metastatic Urothelial Carcinoma who were treated with Avelumab or Pembrolizumab: Real-World Data from a Multi-Institutional Study in Japan

Research Square
2024 | Other
EID:

2-s2.0-85186689238

Contributors: Hirasawa, Y.; Adachi, T.; Hashimoto, T.; Fukuokaya, W.; Koike, Y.; Yata, Y.; Komura, K.; Uchimoto, T.; Tsujino, T.; Nishimura, K. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors

Targeted Oncology
2024 | Journal article
EID:

2-s2.0-85188915289

Part of ISSN: 1776260X 17762596
Contributors: Uchimoto, T.; Tsuchida, S.; Komura, K.; Fukuokaya, W.; Adachi, T.; Hirasawa, Y.; Hashimoto, T.; Yoshizawa, A.; Saruta, M.; Hashimoto, M. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study

International Journal of Clinical Oncology
2024 | Journal article
EID:

2-s2.0-85193497061

Part of ISSN: 14377772 13419625
Contributors: Hara, S.; Mori, K.; Fukuokaya, W.; Tomomasa, N.; Oguchi, T.; Takahashi, Y.; Saito, S.; Katami, J.; Sano, T.; Kadena, S. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study

Urologic Oncology: Seminars and Original Investigations
2024 | Journal article
EID:

2-s2.0-85192458350

Part of ISSN: 18732496 10781439
Contributors: Muramoto, K.; Urabe, F.; Koike, Y.; Yamamoto, S.; Suzuki, H.; Miyajima, K.; Fukuokaya, W.; Iwatani, K.; Imai, Y.; Igarashi, T. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Prognostic impact of histological discordance between transurethral resection and radical cystectomy

BJU International
2024 | Journal article
EID:

2-s2.0-85185120262

Part of ISSN: 1464410X 14644096
Contributors: Matsuda, A.; Taoka, R.; Miki, J.; Saito, R.; Fukuokaya, W.; Hatakeyama, S.; Kawahara, T.; Fujii, Y.; Kato, M.; Sazuka, T. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study

Clinical Genitourinary Cancer
2024 | Journal article
EID:

2-s2.0-85174834982

Part of ISSN: 19380682 15587673
Contributors: Nukaya, T.; Takahara, K.; Yoshizawa, A.; Saruta, M.; Yano, Y.; Ohno, T.; Uchimoto, T.; Fukuokaya, W.; Adachi, T.; Yamazaki, S. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study

International Journal of Urology
2024 | Journal article
EID:

2-s2.0-85173824812

Part of ISSN: 14422042 09198172
Contributors: Suhara, Y.; Urabe, F.; Yoshihara, K.; Kurawaki, S.; Fukuokaya, W.; Iwatani, K.; Imai, Y.; Sakanaka, K.; Hisakane, A.; Kurauchi, T. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer

Clinical Genitourinary Cancer
2024 | Journal article
EID:

2-s2.0-85190741662

Part of ISSN: 19380682 15587673
Contributors: Tashiro, K.; Kimura, S.; Tsuzuki, S.; Urabe, F.; Fukuokaya, W.; Mori, K.; Aikawa, K.; Murakami, M.; Sasaki, H.; Miki, K. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study

International Journal of Urology
2024 | Journal article
EID:

2-s2.0-85180264606

Part of ISSN: 14422042 09198172
Contributors: Fukuokaya, W.; Koike, Y.; Yata, Y.; Komura, K.; Uchimoto, T.; Tsujino, T.; Saruta, M.; Takahara, K.; Fujita, K.; Minami, T. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study

Clinical Genitourinary Cancer
2024 | Journal article
EID:

2-s2.0-85190760685

Part of ISSN: 19380682 15587673
Contributors: Narita, C.; Urabe, F.; Fukuokaya, W.; Iwatani, K.; Imai, Y.; Yasue, K.; Mori, K.; Aikawa, K.; Yanagisawa, T.; Kimura, S. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis

International Journal of Clinical Oncology
2024 | Journal article
EID:

2-s2.0-85179910609

Part of ISSN: 14377772 13419625
Contributors: Shimomura, T.; Mori, K.; Yasue, K.; Matsukawa, A.; Fukuokaya, W.; Yanagisawa, T.; Hata, K.; Murakami, M.; Koike, Y.; Miki, J. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study

International Journal of Urology
2024 | Journal article
EID:

2-s2.0-85180844304

Part of ISSN: 14422042 09198172
Contributors: Nakano, J.; Urabe, F.; Kiuchi, Y.; Takamizawa, S.; Suzuki, H.; Kawano, S.; Miyajima, K.; Fukuokaya, W.; Takahashi, K.; Iwatani, K. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data

Cancer Immunology, Immunotherapy
2024 | Journal article
EID:

2-s2.0-85183630380

Part of ISSN: 14320851 03407004
Contributors: Yanagisawa, T.; Mori, K.; Matsukawa, A.; Kawada, T.; Katayama, S.; Bekku, K.; Laukhtina, E.; Rajwa, P.; Quhal, F.; Pradere, B. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

Targeted oncology
2024-05 | Journal article
Contributors: Uchimoto T; Matsuda T; Komura K; Fukuokaya W; Adachi T; Hirasawa Y; Hashimoto T; Yoshizawa A; Saruta M; Hashimoto M et al.
Source: Self-asserted source
Wataru Fukuokaya via Europe PubMed Central

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study.

International journal of urology : official journal of the Japanese Urological Association
2024-05 | Journal article
Contributors: Miki J; Fukuokaya W; Taoka R; Saito R; Matsui Y; Hatakeyama S; Kawahara T; Matsuda A; Kawai T; Kato M et al.
Source: Self-asserted source
Wataru Fukuokaya via Europe PubMed Central

Abiraterone acetate versus enzalutamide against chemo-naïve castration resistant prostate cancer with full dose induction

2024-04 | Preprint
Contributors: Shimomura T; Mori K; Yasue K; Matsukawa A; Fukuokaya W; Yanagisawa T; Hata K; Murakami M; Koike Y; Urabe F et al.
Source: Self-asserted source
Wataru Fukuokaya via Europe PubMed Central

Radiographic Progression Without Corresponding Prostate-specific Antigen Progression in Patients with Metastatic Castration-sensitive Prostate Cancer Receiving Apalutamide: Secondary Analysis of the TITAN Trial.

European urology oncology
2024-04 | Journal article
Contributors: Fukuokaya W; Yanagisawa T; Mori K; Urabe F; Rajwa P; Briganti A; Shariat SF; Kimura T
Source: Self-asserted source
Wataru Fukuokaya via Europe PubMed Central

Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials

Research Square
2023 | Other
EID:

2-s2.0-85167645350

Contributors: Fukuokaya, W.; Mori, K.; Yanagisawa, T.; Akazawa, K.; Shimomura, T.; Kimura, T.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials

Prostate Cancer and Prostatic Diseases
2023 | Journal article
EID:

2-s2.0-85165067659

Part of ISSN: 14765608 13657852
Contributors: Fukuokaya, W.; Mori, K.; Yanagisawa, T.; Akazawa, K.; Shimomura, T.; Kimura, T.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer

Urologic Oncology: Seminars and Original Investigations
2023 | Journal article
EID:

2-s2.0-85171374701

Part of ISSN: 18732496 10781439
Contributors: Yanagisawa, T.; Sato, S.; Hayashida, Y.; Okada, Y.; Fukuokaya, W.; Iwatani, K.; Matsukawa, A.; Shimoda, M.; Takahashi, H.; Kimura, T. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial

Anticancer Research
2023 | Journal article
EID:

2-s2.0-85150966993

Part of ISSN: 17917530 02507005
Contributors: Miyajima, K.; Yanagisawa, T.; Suzuki, H.; Fukuokaya, W.; Sakanaka, K.; Obayashi, K.; Miki, J.; Kimura, T.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival

Clinical and Translational Radiation Oncology
2023 | Journal article
EID:

2-s2.0-85143975327

Part of ISSN: 24056308
Contributors: Nakamori, K.; Yamazaki, S.; Komura, K.; Fukuokaya, W.; Adachi, T.; Hirasawa, Y.; Hashimoto, T.; Yoshizawa, A.; Ohno, T.; Yano, Y. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy

Prostate
2023 | Journal article
EID:

2-s2.0-85147038682

Part of ISSN: 10970045 02704137
Contributors: Yanagisawa, T.; Hata, K.; Narita, S.; Hatakeyama, S.; Mori, K.; Yata, Y.; Sano, T.; Otsuka, T.; Hara, S.; Miyajima, K. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Efficacy of Systemic Treatment in Prostate Cancer Patients with Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis

Journal of Urology
2023 | Journal article
EID:

2-s2.0-85167481792

Part of ISSN: 15273792 00225347
Contributors: Yanagisawa, T.; Rajwa, P.; Kawada, T.; Mori, K.; Fukuokaya, W.; Petrov, P.; Quhal, F.; Laukhtina, E.; Von Deimling, M.; Bianchi, A. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis

Annals of Surgical Oncology
2023 | Journal article
EID:

2-s2.0-85149732296

Part of ISSN: 15344681 10689265
Contributors: Yanagisawa, T.; Matsukawa, A.; Iwatani, K.; Sato, S.; Hayashida, Y.; Okada, Y.; Yorozu, T.; Fukuokaya, W.; Sakanaka, K.; Urabe, F. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis

Urologic Oncology: Seminars and Original Investigations
2023 | Journal article
EID:

2-s2.0-85145676114

Part of ISSN: 18732496 10781439
Contributors: Aikawa, K.; Yanagisawa, T.; Fukuokaya, W.; Shimizu, K.; Miyajima, K.; Nakazono, M.; Iwatani, K.; Matsukawa, A.; Obayashi, K.; Kimura, S. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer

Cancer Medicine
2023 | Journal article
EID:

2-s2.0-85170695950

Part of ISSN: 20457634
Contributors: Tsujino, T.; Tokushige, S.; Komura, K.; Fukuokaya, W.; Adachi, T.; Hirasawa, Y.; Hashimoto, T.; Yoshizawa, A.; Saruta, M.; Ohno, T. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis

Research Square
2023 | Other
EID:

2-s2.0-85167640813

Contributors: Shimomura, T.; Mori, K.; Yasue, K.; Matsukawa, A.; Fukuokaya, W.; Yanagisawa, T.; Hata, K.; Murakami, M.; Koike, Y.; Miki, J. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases.

Oncology
2023-10 | Journal article
Contributors: Nishio K; Higashio T; Komura K; Fukuokaya W; Adachi T; Hirasawa Y; Hashimoto T; Yoshizawa A; Tsuchida S; Matsuda T et al.
Source: Self-asserted source
Wataru Fukuokaya via Europe PubMed Central

ADVANCES IN THE DIAGNOSIS OF LOCALIZED PROSTATE CANCER,限局性前立腺癌診断の変遷

Nishinihon Journal of Urology
2022 | Journal article
EID:

2-s2.0-85172388206

Part of ISSN: 00290726
Contributors: Fukuokaya, W.; Egawa, S.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma

Research Square
2022 | Other
EID:

2-s2.0-85167249797

Contributors: Fukuokaya, W.; Yanagisawa, T.; Hashimoto, M.; Yamamoto, S.; Koike, Y.; Imai, Y.; Iwatani, K.; Onuma, H.; Ito, K.; Urabe, F. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Laparoscopic partial nephrectomy for the horseshoe kidney with indocyanine green fluorescence guidance under the modified supine position

IJU Case Reports
2022 | Journal article
EID:

2-s2.0-85128866734

Part of ISSN: 2577171X
Contributors: Imai, Y.; Urabe, F.; Fukuokaya, W.; Matsukawa, A.; Iwatani, K.; Aikawa, K.; Obayashi, K.; Yanagisawa, T.; Tsuzuki, S.; Nakajo, H. et al.
Source: Self-asserted source
Wataru Fukuokaya via Scopus - Elsevier

Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab.

Cancers
2022-11-17 | Journal article
Contributors: Yano Y; Ohno T; Kazumasa Komura; Fukuokaya W; Uchimoto T; Adachi T; Hirasawa Y; Hashimoto T; Yoshizawa A; Yamazaki S et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma.

Cancer immunology, immunotherapy : CII
2022-09-14 | Journal article | Author
Contributors: Wataru Fukuokaya; Yanagisawa T; Hashimoto M; Yamamoto S; Koike Y; Imai Y; Iwatani K; Onuma H; Ito K; Urabe F et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.

BJU international
2022-09-13 | Journal article | Author
Contributors: Uchimoto T; Fukushima T; Kazumasa Komura; Wataru Fukuokaya; Adachi T; Hashimoto T; Yoshizawa A; Nakamura K; Yano Y; Nishimura K et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.

European urology
2022-08-19 | Journal article
Contributors: Yanagisawa T; Rajwa P; Thibault C; Gandaglia G; Mori K; Tatsushi Kawada; Fukuokaya W; Shim SR; Mostafaei H; Motlagh RS et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.

World journal of urology
2022-08-13 | Journal article
Contributors: Mori Keiichiro; Yanagisawa T; Katayama S; Laukhtina E; Pradere B; Mostafaei H; Quhal F; Rajwa P; Moschini M; Soria F et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors.

Urologic oncology
2022-03-26 | Journal article
Contributors: Fukuokaya W; Kimura T; Komura K; Uchimoto T; Nishimura K; Yanagisawa T; Imai Y; Iwatani K; Ito K; Urabe F et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma.

Urologic oncology
2022-03-26 | Journal article
Contributors: Uchimoto T; Nakamura K; Komura K; Fukuokaya W; Yano Y; Nishimura K; Kinoshita S; Nishio K; Fukushima T; Nakamori K et al.
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎

Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer

Journal for ImmunoTherapy of Cancer
2022-01 | Journal article
Part of ISSN: 2051-1426
Contributors: Kazuki Nishimura; Kyosuke Nishio; Kensuke Hirosuna; Kazumasa Komura; Takuo Hayashi; Wataru Fukuokaya; Ayako Ura; Taizo Uchimoto; Ko Nakamura; Tatsuo Fukushima et al.
Source: Self-asserted source
Wataru Fukuokaya via Crossref Metadata Search
grade
Preferred source (of 2)‎

The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.

International journal of clinical oncology
2021-10-29 | Journal article | Author
Contributors: koki obayashi; Miki J; Wataru Fukuokaya; Yanagisawa T; Kimura S; Tsuzuki S; Kimura T; Egawa S
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 3)‎

Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer

The Prostate
2021-09 | Journal article
Part of ISSN: 0270-4137
Contributors: Takafumi Yanagisawa; Takahiro Kimura; Keiichiro Mori; Hirotaka Suzuki; Takayuki Sano; Takashi Otsuka; Yuya Iwamoto; Wataru Fukuokaya; Keiichiro Miyajima; Yuki Enei et al.
Source: Self-asserted source
Wataru Fukuokaya via Crossref Metadata Search
grade
Preferred source (of 2)‎

Differences in sex hormone recovery profile after cessation of 12‐week gonadotropin‐releasing hormone antagonist versus agonist therapy

Andrology
2021-09 | Journal article
Part of ISSN: 2047-2919
Contributors: Hiroshi Sasaki; Kenta Miki; Kojiro Tashiro; Keiichiro Mori; Fumihiko Urabe; Wataru Fukuokaya; Takahiro Kimura; Shun Sato; Hiroyuki Takahashi; Manabu Aoki et al.
Source: Self-asserted source
Wataru Fukuokaya via Crossref Metadata Search
grade
Preferred source (of 2)‎

Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer

Japanese Journal of Clinical Oncology
2021-07 | Journal article
Part of ISSN: 1465-3621
Contributors: Shunsuke Tsuzuki; Shota Kawano; Wataru Fukuokaya; Keiichiro Mori; Hideomi Nishikawa; Kojiro Tashiro; Daisuke Watanabe; Taizo Uchimoto; Kazuki Nishimura; Yusuke Yano et al.
Source: Self-asserted source
Wataru Fukuokaya via Crossref Metadata Search
grade
Preferred source (of 2)‎

Risk Classification for Overall Survival by the Neutrophil-Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab-A Multicenter Collaborative Study in Japan.

Cancers
2021-07-15 | Journal article
Part of PMID: 34298768
Source: Self-asserted source
Wataru Fukuokaya
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (3 reviews for 3 publications/grants)

Review activity for Clinical genitourinary cancer. (1)
Review activity for World journal of surgical oncology (1)
Review activity for World journal of urology. (1)